INTRODUCTION
============

Toll-like receptors (TLRs) are primary sensor molecules that play an integral role in innate immunity via their capacity to recognize pathogen-associated molecular patterns that allow the detection of infection and inflammation ([@B1]). TLR stimulation of dendritic cells (DCs) and macrophages promotes the production of pro-inflammatory cytokines and the up-regulation of MHC and co-stimulatory molecules, which leads to the induction of T cell-mediated adaptive immune responses ([@B2]).

Although much of our knowledge of TLR function in the immune system comes from the study of innate immune cells, these molecules also are expressed in T cells. Early studies of TLRs in T cells have been conducted with CD4 T cells. Naïve human CD4 T cells express TLR2 after activation by TCR stimulation and TLR2 functions as a co-stimulatory receptor. Moreover, TLR2 also participates in the generation and maintenance of CD4 T cell memory ([@B3]). TLR3 and TLR9 ligand directly deregulate Bcl-xL in CD4 T cells, thus promoting survival ([@B4]). CpG DNA-mediated co-stimulation in CD4 T cells proceeds through the MyD88-dependent PI-3 kinase signaling pathway ([@B5]). According to a recent study, TLR2 stimulation activates Th1 effector cells without TCR stimulation through the enhanced activation of MAPKs. In contrast, no TLR affects the function of Th2 effector cells ([@B6]).

Several studies have reported the co-stimulatory effects of TLR on CD8 T cells. TLR2 engagement on CD8 T cells decreases the activation threshold for co-stimulatory signals delivered by APC ([@B7]). Quigley et al. showed that direct TLR2-MyD88 signaling in CD8 T cells plays a critical role in clonal expansion and memory formation against vaccinia viral (VV) infection ([@B8]). It has been also reported that MyD88-dependent signals are critical for survival of Lymphocytic choriomeningitis virus (LCMV)-specific CD8 T cells and sustained accumulation for viral clearance ([@B9]). Furthermore, TLR2 engagement on cytotoxic T-lymphocytes (CTL) augments antitumor activity against established B16 melanoma tumors ([@B10]).

Certain co-stimulatory molecules on activated T cells are known to primarily be involved in either the CD4 or CD8 T cell subset. For example, 4-1BB is preferentially involved in CD8 T cell-mediated immune responses ([@B11]). In the present study, we compared the expression and function of TLR2 on CD4 versus (vs.) CD8 T cells, which have not been directly compared yet. However, we found that TLR2 co-stimulation is more responsible for CD8 T cells than for CD4 T cells.

MATERIALS AND METHODS
=====================

Mice
----

Female B6 (H-2^b^) and Balb/c (H-2^d^) mice were purchased from Orient Bio Inc. (Seoul, Korea). TLR2^-/-^ (H-2^b^) mice were provided by S. Akira (Osaka University, Osaka, Japan). All mice were used for the experiments at the age of 8\~10 weeks.

Antibodies and reagents
-----------------------

The following antibodies were purchased from e-Bioscience (San Diego, CA) for flow cytometry: FITC-conjugated anti-mouse CD3 (145-2C11), TLR2 (6C2), and H-2^b^ (AF6-88.5); PE-conjugated anti-mouse CD4 (GK1.5), CD8 (53-6.7), TLR2 (6C2), Bcl-2 (3F11), Bcl-xL (7B2.5), and IFN-γ (XMG1.2); PE-Cy5-conjugated anti-mouse CD4 (GK1.5) and CD8 (53-6.7); purified anti-CD16/32 (2.4G2) and purified anti-TLR2 (T2.5). LLO~91-99~ pentamer was obtained from ProImmune (Oxford, UK). Purified anti-mouse CD3 (145.2C11) was obtained from BD Biosciences (San Jose, CA). Pam~3~CSK~4~ was purchased from Invivogen (Carlsbad, CA).

Cell preparation, culture, and *in vitro* proliferation assay
-------------------------------------------------------------

Naïve T cells were isolated from spleen and lymph nodes of B6 using anti-CD90 (Thy1.2) magnetic beads (Miltenyi Biotech, Auburn, CA) after depletion of CD25^+^ cells. The cells were \>97% CD3 T cells with a naïve phenotype. To prepare the CD4 T and CD8 T cells, CD11c^+^ and CD25^+^ cells were first depleted using anti-CD11c and -CD25 magnetic beads to remove Treg and lymphoid dendritic cells and then the cells were isolated using anti-CD4 or -CD8 magnetic beads, respectively. The cells were \>97% CD3^+^ CD4^+^ or CD8^+^ T cells with a naïve phenotype. 2×10^5^ cells were stimulated with soluble anti-CD3 (0.5 µg/ml) or pulsed with Pam~3~CSK~4~ (2 µg/ml) or LPS (2 µg/ml) for 64 h at 37℃ in a 5% CO2 environment. Proliferation was measured in triplicate cultures by the incorporation of \[^3^H\]thymidine (1 µCi/well, Amersham Pharmacia) during the last 12 h of culture. The incorporation of \[^3^H\]thymidine was measured with a β-counter (Wallac, Torrance, CA). For blocking analysis, purified cells were pretreated with anti-TLR2 antibody (2 µg/ml, T2.5) before the stimulation.

*In vivo* generation of alloantigen activated T cells
-----------------------------------------------------

Responder T cells were purified from the spleen and lymph nodes of B6 (H-2^b^) mice using the anti-CD90 microbead separation system (Miltenyi Biotec). Cells (1×10^7^) were suspended in PBS and transferred into lethally irradiated (1,000 cGy) Balb/c (H-2^d^) recipients via tail vein. Recipient splenocytes were isolated at 4 days after transplant, and cells were identified as donor T cells with anti-H-2^b^ and -CD4 or -CD8 mAb and analyzed by flow cytometry.

*In vivo* generation of Listeria-specific memory CD8 T cells
------------------------------------------------------------

Balb/c mice were infected intravenously (i.v.) with 3000 colony-forming units (CFU) of live *L. monocytogenes*. On day 25, the mice were reinfected with 5000 CFU of live bacteria intraperitoneally (p. i.); 5 days later, LLO~91-99~-specific CD8 T cells were determined using LLO~91-99~ pentamer.

Flow cytometry
--------------

To measure the expression of TLR2, cells were first incubated with FcR blocker (2.4G2) to block nonspecific antibody binding and then stained with PE-anti-TLR2 and PE-Cy5-anti-CD4 or CD8 and analyzed on a FACSCalibur flow cytometer (BD Biosciences) using the CellQuest software. To measure cell proliferation, cultured cells were treated with BrdU (2 µg, Sigma) for 1 h and washed with PBS. The cells were fixed, permeabilized, treated with DNase I, and stained with FITC-anti-BrdU using a BrdU Flow kit according to the manufacturer\'s instructions. To analyze cell death, cells were stained with FITC-annexin V and 7-AAD. To stain Bcl-2 and Bcl-xL, the cells were fixed, permeabilized, and stained with PE-anti-Bcl-2 or -Bcl-xL mAb. To stain intracellular IFN-γ, cells were fixed, permeabilized using the Cytofix/Cytoperm kit (BD Bioscience) according to the manufacturer\'s instructions, and incubated with PE-anti-IFN-γ mAb.

RESULTS
=======

TLR2 expression is preferentially induced on CD8 T cells vs. CD4 T cells
------------------------------------------------------------------------

To assess the expression pattern of TLR2 on CD4 vs. CD8 T cells, we performed flow cytometric analysis on naïve and alloantigen-activated T cells. TLR2 was not expressed on either naïve CD4 or CD8 T cells before adoptive transfer into allogeneic recipient. Four days after transfer, alloantigen-activated responder T cells induced TLR 2 expression. However, the expression levels were much higher on CD8 T cells (45.7±4.8%) than on CD4 T cells (5.4±3.2%) ([Fig. 1A](#F1){ref-type="fig"}). Furthermore, Listeria-specific memory CD8 T cells constitutively expressed TLR2 ([Fig. 1B](#F1){ref-type="fig"}). These data indicate that TLR2 is preferentially expressed on CD8 T cells following activation.

TLR2 co-stimulation dominantly enhances CD8 T cell expansion more than CD4 T cell expansion
-------------------------------------------------------------------------------------------

To test the effect of TLR2 co-stimulation on the proliferation of total T cells or CD4 vs. CD8 T cells, T cells were isolated as described in Materials and Methods and incubated with soluble anti-CD3 (anti-CD3s) in the presence or absence of TLR2 ligand Pam~3~CSK~4~. First, we observed that the co-stimulation of total T cells with Pam~3~CSK~4~ led to a seven-fold enhancement of anti-CD3-induced proliferation ([Fig. 2A](#F2){ref-type="fig"}). We next evaluated the ratio of CD4 vs. CD8 T cells in the proliferative capacity of the total T cell population that was enhanced by TLR2 co-stimulation, and performed the BrdU incorporation assay. [Fig. 2B](#F2){ref-type="fig"} shows that there were more CD8 T cells than CD4 T cells in the increased proliferative capacity of total T cells. To further confirm the direct effect of TLR2 signaling on T cell subsets, we isolated highly purified populations of naïve CD4 or CD8 T cells after the depletion of CD11c^+^ and CD25^+^ cells to remove contaminating lymphoid DCs and natural Treg, respectively (\>97% purity). T cell subsets were then incubated with anti-CD3s in the presence or absence of Pam~3~CSK~4~. The co-stimulation of CD8 T cells with Pam~3~CSK~4~ led to a 11-fold enhancement of anti-CD3-induced proliferation. However, the CD4 cell proliferation was increased five-fold ([Fig. 3](#F3){ref-type="fig"}). Taken together, these results indicate that TLR2 co-stimulation is preferentially involved in CD8 T cell expansion rather than CD4 T cell expansion.

TLR2 co-stimulation elevates CD8 T cell survival more strongly than CD4 T cell survival
---------------------------------------------------------------------------------------

To further assess the effect of TLR2 co-stimulation on the survival of CD4 vs. CD8 T cells, isolated naïve CD4 and CD8 T cells were stimulated with anti-CD3s in the presence or absence of Pam~3~CSK~4~. Survival was then detected by annexin V plus 7-AAD staining at 64 h following activation. Pam~3~CSK~4~ increased the activated CD8 T cell survival from 12% to 40% ([Fig. 4B](#F4){ref-type="fig"}). However, the CD4 T cell survival was increased from 25% to 35% by TLR2 co-stimulation ([Fig. 4A](#F4){ref-type="fig"}). Members of the Bcl family are reported to be key mediators of activated T cell survival following TLR2 co-stimulation ([@B4]). Therefore, we compared the levels of these molecules following TLR2 ligand treatment of CD4 or CD8 T cells. We observed more significant increases in Bcl-xL protein in Pam~3~CSK~4~-treated CD8 T cells than in CD4 T cells. However, Bcl-2 protein levels were similar in CD4 and CD8 T cells ([Fig. 4C](#F4){ref-type="fig"}). These data indicate that TLR2 co-stimulation is preferentially involved in CD8 T cell survival versus that in CD4 T cells. Thus, it is associated with specific Bcl-xL up-regulation.

Specificity of TLR2 co-stimulation
----------------------------------

To exclude the possibility that the effects caused by Pam~3~CSK~4~ were non-specific, we tested the assay using anti-TLR2 monoclonal antibody, which was added to the culture before the stimulation. As shown in [Fig. 5](#F5){ref-type="fig"}, the enhanced proliferation with Pam~3~CSK~4~ was completely reversed in both CD4 and CD8 T cells by anti-TLR2 treatment as was IFN-γ production. In addition, T cells purified from TLR2^-/-^ mice exhibited no response to Pam~3~CSK~4~ in terms of either the proliferation ([Fig. 5A](#F5){ref-type="fig"}) or the IFN-γ production ([Fig. 5B](#F5){ref-type="fig"}), indicating that Pam~3~CSK~4~ acts through TLR2-dependent signaling pathways.

DISCUSSION
==========

TLR in T cells can function as a co-stimulatory molecule for both CD4 and CD8 T cell activation ([@B12]). In this study, we have confirmed that the TLR2 ligand Pam~3~CSK~4~ provides a direct potent co-stimulatory effect on TCR-mediated T cell proliferation. However, we found that TLR2 co-stimulation was biased toward CD8 T cells rather than CD4 T cells. For instance, the addition of Pam~3~CSK~4~ increased the anti-CD3-mediated proliferation of total T cells by 7-fold ([Fig. 2A](#F2){ref-type="fig"}). In this increased proliferative capacity, CD8 T cells were found in a higher proliferative ratio than CD4 T cells ([Fig. 2B](#F2){ref-type="fig"}), which was confirmed on an isolated subset of T cells ([Fig. 3](#F3){ref-type="fig"}). We also observed that TLR2 co-stimulation promoted the survival of CD8 T cells more than that of CD4 T cells ([Fig. 4A, B](#F4){ref-type="fig"}). This was caused not by Bcl-2 but by increased Bcl-xL ([Fig. 4C](#F4){ref-type="fig"}). In fact, the different sensitivity to TLR2 co-stimulation is probably related to the expression levels on CD4 versus CD8 T cells. The surface expression was more highly induced following activation on CD8 T cells compared with that on CD4 T cells ([Fig. 1A](#F1){ref-type="fig"}). Taken together, these results indicate that CD8 T cells preferentially respond to TLR2 co-stimulation.

CD8 T cells are critical for prevention of acute and chronic viral infections ([@B13]) as well as for tumor eradication ([@B14]). In recent studies, the physiological significance of TLR2 on CD8 T cell-mediated effector immune responses has been reported. Quigley et al. reported that TLR2^-/-^ and MyD88^-/-^ CD8 T cells had severely diminished clonal expansion in response to vaccinia viral (VV) infection, which involved the TLR2 co-stimulation on VV-specific CD8 T cells ([@B8]). The study also reported that long-lived memory CD8 T cells could not develop in the absence of direct TLR2-MyD88 signaling. We also observed that TLR2 is constitutively expressed in Listeria-specific memory CD8 T cells ([Fig. 1B](#F1){ref-type="fig"}). Indeed, rapid Listeria-specific memory CD8 T cell formation is affected by primary infection ([@B15]). It may be related to TLR2 expression that is induced on Listeria-specific CD8 T cells during the primary infection time. The TLR2 expression may affect rapid expansion of the memory CD8 T cells during the secondary infection period.

Our data also indicated that TLR2 co-stimulation decreased the threshold for antigen-specific signaling through TCR. We stimulated T cells with soluble anti-CD3 to provide weak TCR-mediated activation. Although, under these conditions, TLR2 signaling effectively elicited the expansion and IFN-γ production of CD8 T cells ([Fig. 5](#F5){ref-type="fig"}), it can be speculated that TLR2 signaling affects autoreactive CD8 T cell responses. Autoreactive T cells recognize autoantigens, which are basically presented by immature DCs that give feeble TCR signaling, resulting in ignorance or anergy ([@B16]). Under pathogen infection conditions, TLR2 signaling enhances the direct pathway of autoreactive T cell activation by co-stimulation as well as the indirect pathway by induction of DC maturation. A number of animal models for autoimmune disease probably involve TLR signaling in their pathogenesis ([@B17],[@B18]). Our data indicate that promoting the expansion and the effector function of CD8 T cells by TLR2 signaling was completely reversed by the anti-TLR2 mAb, T2.5 ([Fig. 5](#F5){ref-type="fig"}), the therapeutic activity of which has been reported in the sepsis model ([@B19]). Therefore, T2.5 might be become a valuable therapeutic agent for CD8 T cell-mediated pathological conditions in the presence of TLR ligand.

Although it has been recently suggested that TLR2 could be particular in its ability to co-stimulate CD4 and CD8 T cells, in this present study, we find that its dominant effect appears to be the regulation of CD8 T cell activation. These observations suggest a potential therapeutic role for this molecule in the management of cancer and chronic infectious diseases as well as autoimmune diseases.
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![Expression of TLR2 on CD4 and CD8 T cells. (A) T cells were isolated from spleen and lymph nodes of naïve B6 mice as described in Materials and Methods and stained with PE-Cy5-anti-CD4 or -CD8 and PE-anti-TLR2, and then analyzed by flow cytometry. The cells were adoptively transferred into lethally irradiated (850 cGy) Balb/c recipient. Recipient splenocytes were isolated on day 4 and stained with mAbs against H-2^d^, TLR2, and CD4 or CD8. The histogram for TLR2 expression was gated on H-2b^+^CD4^+^ or H-2b^+^CD8^+^ cells. (B) Balb/c mice were infected with *L. monocytogenes* and reinfected on day 25 p. i. with 5000 CFU. Splenocytes were isolated on day 5, stained with FITC-anti-CD8 and PE-LLO~91-99~ pentamer, and analyzed by flow cytometry.](in-9-127-g001){#F1}

![TLR2 ligand co-stimulates T cell proliferation in the total T, CD4, and CD8 T cells. Total T cells were isolated as described in Materials and Methods and incubated with anti-CD3s in the presence or absence of TLR2 ligand Pam~3~CSK~4~ (PAM) for 64 h. (A) The T cell proliferation was determined via \[^3^H\]thymidine incorporation. Values are means and standard deviations of data from three independent experiments. ^\*\*^p\<0.001, anti-CD3 vs. anti-CD3+PAM. (B) Cultured cells were treated with BrdU (2 µg) for the last 1 h and stained with PE-anti-CD4 or -CD8 mAb. The cells were then stained for incorporated BrdU and analyzed by flow cytometry. The histogram for BrdU incorporation was gated on CD4^+^ or CD8^+^ cells.](in-9-127-g002){#F2}

![Effect of TLR2 co-stimulation on proliferation of CD4 T cell vs. CD8 T cells. CD4 and CD8 T cells were isolated as described in Materials and Methods and incubated with anti-CD3s in the presence or absence of TLR2 ligand PAM for 64 h. The cultured cells were treated with BrdU (2 µg) for the last 1 h, stained for incorporated BrdU, and analyzed by flow cytometry.](in-9-127-g003){#F3}

![Effect of TLR2 co-stimulation on the survival of CD4 vs. CD8 T cells. Isolated CD4 (A) and CD8 T cells (B) were incubated with anti-CD3s in the presence or absence of TLR2 ligand PAM for 64 h. The cells were harvested, stained with FITC-Annexin-V and 7-AAD, and then analyzed by flow cytometry. %Survival was determined on annexin V-7-AAD-cells. Values are means and standard deviations of data from three independent experiments. ^\*^p\<0.05, ^\*\*^p\<0.001, anti-CD3 vs. anti-CD3+PAM. (C) Cells were harvested and stained for intracellular Bcl-xL or Bcl-2.](in-9-127-g004){#F4}

![Specificity of TLR2 co-stimulation. CD4 and CD8 T cells were isolated from normal or TLR2^-/-^ mice and incubated with anti-CD3s in the presence or absence of TLR2 ligand PAM for 64 h. Other cells were pretreated with purified anti-TLR2 mAb (2 µg/ml) before the stimulation. (A) Cultured cells were treated with BrdU (2 µg) for the last 1 h, stained for incorporated BrdU, and then analyzed by flow cytometry. (B) Cultured cells were treated with brefeldin A for the last 4 h and stained for intracellular IFN-γ.](in-9-127-g005){#F5}
